About the Authors
- Beat Nyfeler
-
Contributed equally to this work with: Beat Nyfeler, Dominic Hoepfner
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Dominic Hoepfner
-
Contributed equally to this work with: Beat Nyfeler, Dominic Hoepfner
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Deborah Palestrant
-
Affiliation Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Christina A. Kirby
-
Affiliation Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Lewis Whitehead
-
Affiliation Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, Massachussetts, United States of America
- Robert Yu
-
Affiliation Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
- Gejing Deng
-
Affiliation Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
- Ruth E. Caughlan
-
Affiliation Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
- Angela L. Woods
-
Affiliation Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
- Adriana K. Jones
-
Affiliation Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
- S. Whitney Barnes
-
Affiliation Novartis Institute for Functional Genomics, Novartis Institutes for Biomedical Research, San Diego, California, United States of America
- John R. Walker
-
Affiliation Novartis Institute for Functional Genomics, Novartis Institutes for Biomedical Research, San Diego, California, United States of America
- Swann Gaulis
-
Affiliation Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Ervan Hauy
-
Affiliation Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Saskia M. Brachmann
-
Affiliation Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Philipp Krastel
-
Affiliation Center for Proteomic Chemistry, Natural Products Unit, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Christian Studer
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Ralph Riedl
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland
- David Estoppey
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Thomas Aust
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland
- N. Rao Movva
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Zuncai Wang
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Michael Salcius
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Gregory A. Michaud
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Gregory McAllister
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Leon O. Murphy
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- John A. Tallarico
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Christopher J. Wilson
-
Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America
- Charles R. Dean
-
* E-mail: charlesr.dean@novartis.com
Affiliation Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
Competing Interests
The authors are, at present, or were during the time of their contribution to this manuscript, employed by Novartis Pharmaceuticals, under the umbrella of the Novartis Institutes for Biomedical Research (NIBR). As such, the authors all own stock in Novartis as part of their remuneration for employment. There are no competing interests as regards consultancies, patents or products in development or currently marketed. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CRD BN DH DP CK GD. Performed the experiments: REC ALW AKJ SWB RY CS RR TA DE BN ZW MS EH. Analyzed the data: CRD BN DH SWB LW JRW GAM GM LOM CJW SG SMB JT NRM. Contributed reagents/materials/analysis tools: PK. Wrote the paper: CD BN DH CK.